Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Figitumumab (CP-751871) is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor (IGF1R) with high potency. By inhibiting the binding of IGF1 to IGF1R, figitumumab achieves an IC50 value of 1.8 nM, effectively blocking the receptor's activation [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Figitumumab (CP-751871) is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor (IGF1R) with high potency. By inhibiting the binding of IGF1 to IGF1R, figitumumab achieves an IC50 value of 1.8 nM, effectively blocking the receptor's activation [1]. |
Molecular Weight | N/A |
CAS No. | 943453-46-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Figitumumab 943453-46-1 inhibitor inhibit